Guiding catheter aspiration to prevent embolic events during saphenous vein graft intervention

Journal of Interventional Cardiology

Volumn 15, Issue 6, 2002, Pages 491-498

  Morales, Philip A ^a   Heuser, Richard R ^a  

^a Phoenix Heart Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ADULT; AGED; ARTERY CATHETER; ARTERY OCCLUSION; ASPIRATION; BALLOON CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CREATINE KINASE BLOOD LEVEL; DEVICE; ELECTROCARDIOGRAM; EMBOLISM; HUMAN; MALE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; SYMPTOM; TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0036893255     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2002.tb01094.x     Document Type: Conference Paper

References (4)

1. Cordero-Yordan H, Loper A, Heuser RR. Saphenous vein graft intervention. J Interven Cardiol 1999;12:495-498.
2. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290.
3. Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 1999;100:2400-2405.
4. Heuser RR, U.S.P.T.O #6,364,900. Embolism Prevention Device.